Northern Trust
VERA icon

Northern Trust’s Vera Therapeutics VERA Stock Holding History

Northern Trust’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9M Buy
581,126
+61,681
+12% +$2.3M ﹤0.01% 1666
2026
Q1 		$20.9M Buy
519,445
+46,226
+10% +$1.99M ﹤0.01% 1658
2025
Q4 		$24M Buy
473,219
+11,959
+3% +$425K ﹤0.01% 1549
2025
Q3 		$13.4M Buy
461,260
+750
+0.2% +$17.3K ﹤0.01% 1937
2025
Q2 		$10.8M Buy
460,510
+42,251
+10% +$950K ﹤0.01% 2025
2025
Q1 		$10M Sell
418,259
-36,748
-8% -$1.18M ﹤0.01% 2032
2024
Q4 		$19.2M Buy
455,007
+89,707
+25% +$3.97M ﹤0.01% 1714
2024
Q3 		$16.1M Sell
365,300
-219
-0.1% -$8.31K ﹤0.01% 1768
2024
Q2 		$13.2M Sell
365,519
-6,935
-2% -$275K ﹤0.01% 1828
2024
Q1 		$16.1M Buy
372,454
+50,619
+16% +$1.8M ﹤0.01% 1741
2023
Q4 		$4.95M Buy
321,835
+26,331
+9% +$334K ﹤0.01% 2526
2023
Q3 		$4.05M Buy
295,504
+18,041
+7% +$310K ﹤0.01% 2568
2023
Q2 		$4.45M Buy
277,463
+84,078
+43% +$759K ﹤0.01% 2568
2023
Q1 		$1.5M Buy
193,385
+67,904
+54% +$524K ﹤0.01% 3069
2022
Q4 		$2.43M Buy
125,481
+10,611
+9% +$192K ﹤0.01% 2890
2022
Q3 		$2.45M Buy
114,870
+2,400
+2% +$44.9K ﹤0.01% 2908
2022
Q2 		$1.53M Buy
112,470
+3,063
+3% +$53.5K ﹤0.01% 3200
2022
Q1 		$2.57M Buy
109,407
+31,554
+41% +$679K ﹤0.01% 2966
2021
Q4 		$2.08M Buy
77,853
+18,538
+31% +$410K ﹤0.01% 3205
2021
Q3 		$1.03M Buy
+59,315
New +$1.06M ﹤0.01% 3543

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust's VERA Position: Q2 2026 in Review

Northern Trust increased its Vera Therapeutics (VERA) stake by 12% in Q2 2026, buying an estimated $2.3M and bringing the position to 581,126 shares worth $24.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

Northern Trust first reported a position in VERA in Q3 2021 and has held it in 20 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Northern Trust held 581,126 shares of Vera Therapeutics worth $24.9M as of Q2 2026.
  • Northern Trust bought 61,681 Vera Therapeutics shares in Q2 2026, an estimated $2.3M.
  • Vera Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1666 holding.
  • Northern Trust first reported a position in Vera Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.